Your browser doesn't support javascript.
loading
Development of a TB vaccine trial site in Africa and lessons from the Ebola experience.
Kaguthi, G; Nduba, V; Rabuogi, P; Okelloh, D; Ouma, S G; Blatner, G; Gelderbloem, S; Mitchell, Ellen M H; Scott, Cherise P; Verver, S; Hawkridge, T; de Steenwinkel, J E M; Laserson, K F; Richardus, J H.
Afiliação
  • Kaguthi G; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya. gkaguthi@kemri.org.
  • Nduba V; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. gkaguthi@kemri.org.
  • Rabuogi P; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya. gkaguthi@kemri.org.
  • Okelloh D; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.
  • Ouma SG; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
  • Blatner G; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.
  • Gelderbloem S; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
  • Mitchell EMH; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.
  • Scott CP; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
  • Verver S; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.
  • Hawkridge T; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya.
  • de Steenwinkel JEM; AERAS (at the time of the studies), Cape Town, South Africa.
  • Laserson KF; AERAS (at the time of the studies), Rockville, Maryland, USA.
  • Richardus JH; AERAS (at the time of the studies), Cape Town, South Africa.
BMC Public Health ; 20(1): 999, 2020 Jun 26.
Article em En | MEDLINE | ID: mdl-32586316

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacina BCG / Surtos de Doenças / Ensaios Clínicos como Assunto / Programas de Imunização Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacina BCG / Surtos de Doenças / Ensaios Clínicos como Assunto / Programas de Imunização Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article